Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer
Clinical trial NCT06697782 · COMPLETED
Trial details
- NCT number
- NCT06697782
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2024-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.